{
  "url": "https://openlegislation.uk/eu-directive-1992-29/annex-II/division-I",
  "json_url": "https://openlegislation.uk/eu-directive-1992-29/annex-II/division-I.json",
  "legislation": "eudr/1992/29",
  "legislation_title": "Council Directive 92/29/EEC of 31 March 1992 on the minimum safety and health requirements for improved medical treatment on board vessels",
  "legislation_url": "https://openlegislation.uk/eu-directive-1992-29",
  "path": "annex/II/division/I",
  "kind": "division",
  "number": "I",
  "heading": "MEDICINES",
  "text": "Categories of vessels\nA\nB\nC\n1. Cardiovascular\n(a) Cardio-circulatory sympathomimetics\nx\nx\n(b) Anti-angina preparations\nx\nx\nx\n(c) Diuretics\nx\nx\n(d) Anti-haemorrhagics including uterotonics if there are women on board\nx\nx\n(e) Anti-hypertensive\nx\nx\n2. Gastro-intestinal system\n(a) Medicines for gastric and duodenal disorders\n— Medicine for treatment of stomach ulcer and gastritis\nx\nx\n— Anti-acid mucous dressings\nx\nx\n(b) Anti-emetics\nx\nx\n(c) Laxatives\nx\n(d) Anti-diarrhoeals\nx\nx\nx\n(e) Haemorrhoid preparations\nx\nx\n3. Analgesics and anti-spasmodics\n(a) Analgesics, anti-pyretics and anti-inflammatory preparations\nx\nx\nx\n(b) Powerful analgesics\nx\nx\n(c) Spasmolytics\nx\nx\n4. Nervous system\n(a) Anxiolytics\nx\nx\n(b) Neuroleptics\nx\nx\n(c) Seasickness remedies\nx\nx\nx\n(d) Anti-epileptics\nx\nx\n5. Anti-allergics and anti-anaphylactics\n(a) Anti-histaminics\nx\nx\n(b) Glucocorticoids\nx\nx\n6. Respiratory system\n(a) Bronchiospasm preparations\nx\nx\n(b) Anti-tussives\nx\nx\n(c) Medicines used for colds and sinusitis\nx\nx\n7. Anti-infection\n(a) Antibiotics (at least two classes)\nx\nx\n(b) Anti-parasitics\nx\nx\n(c) Anti-tetanus vaccines and immunoglobulins\nx\nx\n(d) Anti-malaria medicines, carriage shall be dependent upon operational area\nx\nx\n8. Compounds promoting rehydration, caloric intake and plasma expansion\nx\nx\n9. Medicines for external use\n(a) Skin medicines\n— Antiseptic solutions\nx\nx\nx\n— Antibiotic ointments\nx\nx\n— Anti-inflammatory and analgesic ointments\nx\nx\n— Anti-mycotic skin creams\nx\n— Burn preparations\nx\nx\nx\n(b) Eye medicines\n— Antibiotic and anti-inflammatory\nx\nx\n— Anaesthetic drops\nx\nx\n— Saline solution for eyewash\nx\nx\nx\n— Hypotonic myotic drops\nx\nx\n(c) Ear medicines\n— Anaesthetic and anti-inflammatory solutions\nx\nx\n(d) Medicines for oral and throat infections\n— Antiseptic mouthwashes\nx\nx\n(e) Local anaesthetics\n— Local anaesthetics using freezing\nx\n— Local anaesthetics given by subcutaneous injection\nx\nx",
  "extent": "E+W+S+N.I.",
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "F",
      "label": "F1",
      "text": "Substituted by Commission Directive (EU) 2019/1834 of 24 October 2019 amending Annexes II and IV to Council Directive 92/29/EEC as regards purely technical adaptations."
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/eudr/1992/29/annex/II/division/I",
    "retrieved_at": "2026-11-01T15:23:23.034157+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}